September 28, 2022 Clinical Research Still lots to investigate to determine if weekly nightmares during middle age are linked to higher dementia risk
September 21, 2022 Clinical Research New hypothesis proposes that Alzheimer’s is principally a disorder of the immune system within the brain. This, given alleged fabricated data in paper published in Nature in 2006, linking beta-amyloid as the causative agent.
September 20, 2022 Clinical Research There is no ‘exercise pill” but the research on the effects of physical activity on the body could lead to treatments to help those with conditions/illnesses that hamper their ability to exercise.
September 12, 2022 Allergy/Immunology Tweaking CAR-T activity with on/off switches may reduce cytokine release syndrome.
September 7, 2022 Clinical Research The observational study claims for ivermectin’s efficacy continue but the evidence from RCTs continues to show that it is not a treatment for COVID.
August 30, 2022 Cardiovascular Diesase Unpublished observational study presented at the European Society of Cardiology conference reports that poor sleep could lead to increased cardiovascular disease risk.
August 29, 2022 Cardiovascular Diesase Study shows that post MI use of polypill combination of ASA, ACE-inhibitor, and statin as opposed to individual pill forms improved secondary prevention outcomes due to better adherence to treatment.
August 19, 2022 Allergy/Immunology Discovery of largely unchanged ‘weak spot’ in COVID-19 variants could lead to better treatment options
August 10, 2022 Allergy/Immunology A vaccine for Lyme disease is in its Phase 3 trial. Results to date show efficacy and safety. If trial is successful, official authorization expected in 2025.
August 9, 2022 Allergy/Immunology Scientists from Johns Hopkins University have genetically engineered an experimental nanobody that targets alpha-synuclein protein clumps thought to be involved in the pathophysiology of Parkinson’s disease
